Freenome FRNM
NASDAQ FRNM
$13.95 -0.14 (-0.99%)
As of: Aug 27, 2026 · 3:59 PM EDT

Freenome (FRNM) Change in Accured Expenses (2025 - 2026)

Freenome (FRNM) posted quarterly Change in Accured Expenses of $772912.0 for Q2 2026, up 4860.29% year-over-year from $15582.0 in Q2 2025, and up 28.62% quarter-over-quarter from $600921.0 in Q1 2026.

Freenome (FRNM) Change in Accured Expenses (2025 - 2026) Analysis & Trends

Freenome's Change in Accured Expenses history runs 2 years deep, the most recent figure standing at $772912.0 for Q2 2026.

  • In Q2 2026, Change in Accured Expenses rose 4860.29% year-over-year to $772912.0; the TTM figure through Jun 2026 stood at $3.3 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, up 869.32% from the prior year.
  • Change in Accured Expenses for Q2 2026 stood at $772912.0, up from $600921.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $1.3 million in Q4 2025, with the low at $15582.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -249.00 Mn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -39.33 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 92.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 23.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -24.00 Mn
10 Freenome 152.52 Mn 152.52 Mn - 772,912.00

Historic Data

Download Data
DateValue
Jun 30, 2026 772,912.00
Jun 30, 2026 772,912.00
Mar 31, 2026 600,921.00
Mar 31, 2026 600,921.00
Dec 31, 2025 1.32 Mn
Dec 31, 2025 1.32 Mn
Sep 30, 2025 653,403.00
Sep 30, 2025 653,403.00
Jun 30, 2025 15,582.00
Jun 30, 2025 15,582.00
Mar 31, 2025 54,761.00
Mar 31, 2025 54,761.00